(lp0
S"Is MannKind Corporation Getting Ready to Sell? Motley Fool - Apr 10, 2017 In just over four months in 2017, MannKind Corporation  stock has lost more than half of its value. It seems that nothing can go right for the long-suffering biotech.Here's Our Take On MannKind Corporation 's Current Situation - Insider FinancialMannKind Corporation  Plunges 5.26% on April 10 - Equities.com"
p1
aS'MannKind Corporation  Plunges 5.26% on April 17 Equities.com - 11 hours ago MannKind Corporation  had a rough trading day for Monday April 17 as shares tumbled 5.26%, or a loss of $-0.07 per share, to close at $1.26.MannKind Corporation  added to 27 new portfolios - Post AnalystMost Recent Analysts Ratings MannKind Corp.  - News Oracle'
p2
aS"Could MannKind Corporation's Marketing Blitz Pay Off? Motley Fool - Mar 21, 2017 For MannKind Corporation , positives have been few and far between for quite a while. The biotech's stock price is down nearly 80% over the last 12 months.What MannKind's Cash Situation Truly Looks Like - Seeking AlphaWhy to Keeping Eye on MannKind Corporation , Keane Group, Inc. ? - StockNewsJournal"
p3
aS'MannKind Corp.: Bleeding Out And On Its Deathbed Seeking Alpha - Mar 30, 2017 In July of 2016, MannKind Corporation  lost its partnership agreement with pharmaceutical juggernaut Sanofi  for the commercialization of its only FDA-approved drug, Afrezza, and subsequently relaunched the product without a&nbsp;...'
p4
aS"MannKind: White Elephant For Sale? Seeking Alpha - Apr 7, 2017 The reality being that MannKind's leadership publicly confirms they consume $10 million dollars per month to keep the corporation operating. Therefore, for the two years their product has been available for generating enough money to pay their ...Stock Volatility Risk Alert: MannKind Corporation Realized Volatility Hits An ... - CML NewsWhy MannKind Corporation  Shares Popped on Friday - Insider Monkey "
p5
aS'MannKind: Afrezza Scripts Remain Underwhelming Seeking Alpha - Apr 3, 2017 MannKind  is running out of options, leverage, time, and excuses. That is the simple reality that the company and its investors must face.MannKind Corporation  Plunges 7.14% on April 05 - Equities.comChallenging Times For MannKind Corporation ? - StockNewsUnion'
p6
aS"Taking a Page Out of David Shaw's Investment Book: MannKind Corporation (MNKD ... Smarter Analyst - Apr 7, 2017 When taking a gander at the biotech sector, what does a numbers master whose billions are rooted in keen numbers know-how think of players like MannKind Corporation , Valeant Pharmaceuticals Intl Inc , and Gilead Sciences&nbsp;..."
p7
aS'Equity Focus: Looking Closer at Shares of MannKind Corporation  Benton Bulletin - 16 hours ago MannKind Corporation  presently has a Piotroski F-Score of 5. The goal of the F-Score is to help locate companies with strengthening balance sheets, and to weed out poor performers.'
p8
aS'MannKind Corporation  Plunges 5.07% on April 12 Equities.com - Apr 12, 2017 MannKind Corporation  had a rough trading day for Wednesday April 12 as shares tumbled 5.07%, or a loss of $-0.07 per share, to close at $1.31.MannKind Corporation  Analytical Review - The Newburgh PressMannKind Corporation  Announce REVERSED - FinancialsTrend'
p9
aS'MannKind Corporation Risk Points versus Health Care CML News - Mar 30, 2017 This is a scatter plot analysis of the critical risk points from the option market for MannKind Corporation  compared to its own past and the Health Care ETF.MannKind Corporation  Moves Lower on Volume Spike for March 31 - Equities.comLookout for Price Target? MannKind Corporation , Pier 1 Imports, Inc.  - StockNewsJournal'
p10
a.